CYNTHIA
D. ANDJELIC |
University
of Utah College of Pharmacy |
Major
|
Pharmacology/Toxicology |
GPA: |
3.9/4.0 |
Graduation
Date: |
Jul-06 |
Focus
of Research: |
Natural
compounds often lead to the discovery of new novel therapeutic targets
and treatments. Papuamides A and B are two cyclic depsineptides which
were isolated from Theonella sponges. These two compounds exhibit
strong activity against human immunodeficiency virus induced cytopathicity.
Research will focus on determining the papuamides anti-HIV mechanism
of action. |
Title
of Dissertation: |
“Mechanism
of Papuamide A and B Inhibition of Human Immunodeficiency Virus Induced
Cytopathicity.” |
Degrees
Received: |
B.S.,
Biology, University of South Florida, December 2000
A.A., General Studies, Pasco-Hernando Community College, May 1998 |
Honors
Received: |
2000-1996,
Florida Bright Futures Scholarship |
AFPE
Award: |
AAPS-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
JOHN D.
BAUER |
Mercer
University School of Pharmacy |
Major
|
Medicinal/Pharmaceutical
Chemistry |
GPA:
|
3.56/4.0 |
Graduation
Date: |
May-07 |
Focus
of Research: |
Modification
of the aryl-acetic acid template, characteristic of non-selective
COX inhibitors, to one in which the carboxylic acid moiety is replaced
by a sulfonamide substituent in order to induce selectivity of the
COX-II isozyme |
Title
of Dissertation: |
“The
Design, Synthesis, and Evaluation of Novel m-Terpheny1-methane Sulfonamides
as Non-steroidal Anti-inflammatory Agents.” |
Degrees
Received: |
B.S.,
Biochemistry, State University of New York at Buffalo, May 2001 |
Honors
Received: |
2003,
Patrick J.D’Souza Award; 2003-02, Pharmacy Dean’s Award |
AFPE
Award: |
Pfizer-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
MELINA
Z. BAYRAMYAN |
University
of Southern California School of Pharmacy |
Major: |
Pharmaceutical
Sciences |
GPA: |
3.90/4.00 |
Graduation
Date: |
May-05 |
Focus
of Research |
To
develop a new computational SELEX method to enhance the process of
aptamer discovery. This involves the development of a computer algorithm
for the generation of nucleic acid structure, which will be extended
to study of RNA-protein interaction and biomolecular conformational
transitions. |
Title
of Dissertation: |
“In
Silico Aptamer Design: Computational SELEX.” |
Degrees
Received: |
Pharm.D., University of Southern California, May 2000 |
Honors
Received: |
2003, Outstanding Teaching Assistant; 2003-02, AFPE Pre-Doctoral Fellowship;
2003, Rho Chi Honor Society member; 2002, USC Representative at GPEN;
2000, Organization of Istanbul Armenian Scholarship; 1999, International
Pharmacy Internship, OU Australia; 1998, Research Fellowship; 2000-97,
Margaret and John Biles Fellowship; 1996, Dean’s Honor List, USC;
1995, Award from College Women’s Club of Pasadena; 1996-93, Dean’s
Honor List; 1995-93, National Dean’s List |
AFPE
Award: |
Josiah Kirby Lilly Sr. Memorial Fellowship in Pharmaceutical Science |
KRISTIN
BIGOS |
University
of Pittsburgh School of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA:
|
3.89/4.0 |
Graduation
Date: |
Apr-07 |
Focus
of Research: |
To
evaluate the differences between the pharmacokinetics and pharmacodynamics
(acute psychological and neuroendocrine response) of intravenous infusion
versus oral administration of citalopram in patients with OCD. Pharmacokinetic
parameters will be used to evaluate citalopram disposition between
treatments. Acute response will be evaluated by measures of depression
and anxiety, and concentrations of prolactin, cortisol, DHEA, and
DHEA-S. Genotypic differences in drug metabolizing enzymes, transporters
and receptors associated with citalopram will also be evaluated. |
Title
of Dissertation: |
“Pharmacokinetics
and Pharmacodynamics of Intravenous Citalopram in Patients with Obsessive
Compulsive Disorder.” |
Degrees
Received: |
B.S.,
Premedicine, Pennsylvania State University, May 2001 |
Honors
Received: |
N/A |
AFPE
Award: |
Bayer
HealthCare-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
SETH BRADFORD |
Ohio
State University College of Pharmacy |
Major
|
Medicinal/Pharmaceutical
Chemistry |
GPA:
|
3.65/4.0 |
Graduation
Date: |
Aug-07 |
Focus
of Research: |
To
test the hypothesis that RNA structure is complex enough to serve
as a basis for designing compounds that bind to it selectively based
on this structure. Another important hypothesis to be tested is whether
or not the use of metal complexes to selectively cleave structured
RNA molecules can be achieved and the determination of how useful
this may be therapeutically. |
Title
of Dissertation: |
“Studies
of the Oxidative Cleavage of RNA: Design of Peptide-metal Complexes
for the Targeted Cleavage of Structured RNA Molecules of Therapeutic
Interest.” |
Degrees
Received: |
B.S.,
Chemistry, University of Akron, May 2002
B.S., Biology, University of Akron, May 2002 |
Honors
Received: |
2002,
Chemistry-Biology Interface Training Grant; 2002, Chemistry Faculty
Award; 2001, Pittsburgh ACS Award for Analytical Chemistry; 2001,
Harwood Scholarship (Chemistry); 2001, Oelschlager Award for Leadership;
2000, Roger F. Keller Award for Genetics/Biotechnology |
AFPE
Award: |
Abbott
Laboratories Fund-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
IRA BUCKNER |
University
of Iowa College of Pharmacy |
Major
|
Pharmaceutics/Biopharmaceutics |
GPA:
|
4.0/4.0 |
Graduation
Date: |
May-07 |
Focus
of Research: |
A
unique compression calorimeter has been used to determine work and
heat changes taking place within powder samples during compaction.
Collection of such data has allowed the calculation of internal energy
changes associated with the compaction process. Many methods of thermodynamic
analysis have been developed and may be applied to characterization
of compaction induced energy changes. The focus of the current research
is to investigate complimentary calorimetric methods for comparison
with previous results obtained from the compression calcrimeter. |
Title
of Dissertation: |
“Investigations
into the Thermodynamic Changes Induced by Compaction of Pharmaceutical
Materials.” |
Degrees
Received: |
B.S.,
Chemistry, Illinois State University, May 1999 |
Honors
Received: |
2003,
Gullory Graduate Fellowship; 2002, UI Presidential Graduate Fellowship;
1999, ACS Undergraduate Analytical Chemistry Award; 1998, Hypercube
Undergraduate Physical Chemistry Award |
AFPE
Award: |
Pfizer-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
RYAN J.
CASE |
University
of Illinois at Chicago College of Pharmacy |
Major
|
Pharmacognosy |
GPA:
|
4.80/5.00 |
Graduation
Date: |
Jun-06 |
Focus
of Research: |
The
documentation of plants used within Manus Province, Papua New Guinea
to treat malaria and tuberculosis including an assessment of their
potential to supplement treatment of tuberculosis through chemical
and biological analysis. A goal is to improve community awareness
of herbal treatments for malaria and tuberculosis. |
Title
of Dissertation: |
“Scientific
Validation of Plants Used by the People of Manus Province, Papua New
Guinea, to Treat Malaria and Tuberculosis.” |
Degrees
Received: |
B.S.,
Plant Biology, University of Delaware, January 2001 |
Honors
Received: |
2003,
AFPE Pre-Doctoral Fellow; 2003, Lloyd Yale Memorial Scholarship; 2003,
Anne Chatham Award; 2001-1997, Carvel State Scholar; 2001-1997, Delaware
Governor’s Scholarship; 2000, Undergraduate Research Grant; 1999,
Outstanding Freshman Academics; 1999, Science and Engineering Scholar;
1998, First Year Honors Certificate |
AFPE
Award: |
USP-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
MARCIA
CHEW |
University
of Pittsburgh School of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA:
|
3.98/4.0 |
Graduation
Date: |
May-07 |
Focus
of Research: |
To
1) investigate the association between SAA levels and cognitive performance,
self-care capacity, and behavioral disturbances in non-demented and
demented recipients of a long-term care facility, 2) assess the stability
of SAA levels across time and whether or not the relationship between
SAA and clinical assessments (e.g. cognitive and behavioral) is stable
overtime, 3) examine the association between mediation changes and
SAA levels and performance on clinical assessments. |
Title
of Dissertation: |
“Anticholinergic
Activity in Long-Term Care Residents.” |
Degrees
Received: |
B.S.,
Molecular Biology, University of Pittsburgh, April 1996 |
Honors
Received: |
2003,
Glenn/AFAR Scholarship; 2001-00, Albert Schweitzer Fellowship; 1996-95,
Lawler Memorial Scholarship; 1996-92, University Scholarship; 1996-92,
Greensburg Italian Women’s Club Scholarship; 1995, Study Abroad Scholarship;
1995, Semester at Sea Alumni Scholarship; 1994, Howard Hughes Summer
Fellow |
AFPE
Award: |
NACDS-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
PADMANABH
CHIVUKULA |
University
of Utah College of Pharmacy |
Major
|
Medicinal/Pharmaceutical
Chemistry |
GPA:
|
3.84/4.0 |
Graduation
Date: |
Jun-07 |
Focus
of Research: |
The
use of an oral colon specific hydrogel delivery system for the delivery
of a peptide (calcitonin) designed for the treatment of osteoporosis.
The research will include the synthesis and evaluation of IPN hydrogels
composed from pH-sensitive, aromatic azo group containing hydrogel
as the first component, and a hydrolyzable network as the second. |
Title
of Dissertation: |
“IPN
Hydrogels For Colon Specific Drug Delivery.” |
Degrees
Received: |
B.S.,
Chemistry, University of Utah, June 2001 |
Honors
Received: |
N/A |
AFPE
Award: |
Bristol-Myers
Squibb-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
LINDSAY
R. COMSTOCK |
University
of Wisconsin-Madison School of Pharmacy |
Major:
|
Pharmaceutical
Sciences |
GPA:
|
3.71/4.0 |
Graduation
Date: |
Aug-05 |
Focus
of Research: |
To
explore DNA modifying agents that derive sequence specificity from
DNA methyltransferases. Specifically, they will be utilized in combination
with aziridine-based cofactor mimics. The resulting lesions will undergo
further conjugation with a DNA reactive pharmacophore, creating conjugates
capable of DNA damage. |
Title
of Dissertation: |
”Aziridine
Base Cofactor Mimics: Synthesis and Biological Evaluation of Methyltransferase
Dependent DNA Alkylation.” |
Degrees
Received: |
B.S.,
Chemistry, Northern Arizona University, May 2000 |
Honors
Received: |
2003,
AFPE Pre-Doctoral Fellow, 2000, Outstanding Chemistry Senior; 1997,
Outstanding General Chemistry Award |
AFPE
Award: |
AACP-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
WENDY CUMMINGS |
Duquesne
University Mylan School of Pharmacy |
Major
|
Pharmacology/Toxicology |
GPA:
|
3.8/4.0 |
Graduation
Date: |
May-05 |
Focus
of Research: |
The
use of site-directed mutagenesis and radioligand binding assays in
combination to test an hypothesized mechanism of mu-Opiod and MT1
Receptor. Determining the critical amino acid residues involved in
mu-Opiod Receptor activation may help explain structure-function relationships
of opioid drugs and may be exploited to improve selectivity of these
agents. |
Title
of Dissertation: |
“The
Role of the Transmembrane NPxxY Motif in mu-Opioid and MT1 Receptor
Activation.” |
Degrees
Received: |
B.S.,
Biochemistry, University of Arizona, May 1998 |
Honors
Received: |
2003,
Graduate Award-Teaching Excellence; 2003 Guest Lecturer-Forensic Science;
1998, President’s Award for Excellence; 1997, FBI Honors Intern; 1994,
Bronze Congressional Award |
AFPE
Award: |
Novartis-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
EDGAR DIAZ-CRUZ |
Ohio
State University College of Pharmacy |
Major
|
Medicinal/Pharmaceutical
Chemistry |
GPA:
|
3.70/4.0 |
Graduation
Date: |
Sep-05 |
Focus
of Research: |
Epidemiological
observations have stated the beneficial effects of nonsteroidal anti-inflammatory
drugs (NSAIDs) on breast cancer. The focus of this research is to
explore the interrelationship between aromatase and cyclooxygenases
in both normal and cancerous breast tissue, by examining the effects
of NSAIDs on the aromatase activity and expression. |
Title
of Dissertation: |
“Aromatase
Activity and Expression: Unraveling the Relevance of Cyclooxygenase
Inhibitors in Breast Cancer.” |
Degrees
Received: |
M.S.,
Medicinal Chemistry, University of Puerto Rico, December 2001
B.S., Chemistry, University of Puerto Rico, May 1997 |
Honors
Received: |
2004,
Edward F. Hayes Graduate Research Forum Award; 2002, Rho Chi Pharmacy
Honor Society; 2001, Chemistry-Biology Interface Training Program;
2000, Molecular Life Sciences Fellowship; 2000, University Minority
Fellowship; 1998, Bridge to Ph.D. for Minority Students (NIH); 1996,
Analytical Chemistry Award (ACS) |
AFPE
Award: |
Bristol-Myers
Squibb-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
P. THERESE
DOWNING |
University
of California at San Francisco School of Pharmacy |
Major
|
Medicinal/Pharmaceutical
Chemistry |
GPA:
|
3.8/4.0 |
Graduation
Date: |
Jun-06 |
Focus
of Research: |
To
1) Optimize the DOCK suite of programs for RNA targets, and 2) develop
a new scheme for docking small molecules to RNA by allowing fully
flexible receptor and ligand. These techniques will be applied to
designing a novel inhibitor for the HIV 1 target TAR RNA. |
Title
of Dissertation: |
“Development
and Optimization of Theoretical Techniques for Screening Libraries
Against RNA Targets.” |
Degrees
Received: |
B.A.,
Chemistry/Biochemistry, LaSalle University, May 2001 |
Honors
Received: |
2004-02,
Burroughs Wellcome Fellowship; 2002-01, Burroughs Wellcome Traineeship;
2001, Graduate Dean Fellow in Health Science; NSF Fellowship-Honorable
Mention; 2001, LaSalle Chemistry Best of Class; 2001, Maxima Cum Laude |
AFPE
Award: |
Janssen-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
KERRY M.
EMPEY |
University
of Kentucky College of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA:
|
3.9/4.0 |
Graduation
Date: |
May-06 |
Focus
of Research: |
Identifying
areas within the neonatal pulmonary immune response that are delayed
or deficient and using immunomodulatory agents to overcome this deficiency.
We have determined that alveolar macrophages play a crucial role in
the clearance of Pneumocystis in mice. We have further demonstrated
neonatal alveolar macrophages do not become activated in response
to Pneumocystis in contrast to adults. It is the goal of the research
to determine if immunomodulatory agents, such as granulocyte colony
stimulating factor (GM-CSF), will improve the neonatal alveolar macrophage
activation and expedite the clearance of organisms like Pneumocystis. |
Title
of Dissertation: |
“Response
of Neonatal Alveolar Macrophages to Immunostimulation and Clearance
of Pneumocystis Infection.” |
Degrees
Received: |
Pharm.D.,
University of Rhode Island, May 1999 with High Distinction |
Honors
Received: |
1999,
Merck Scholastic Achievement Award; 1999-94, Golden Key National Honor
Society; 1999-93, Dean’s List |
AFPE
Award: |
Donald
and Frances Brodie Pre-Doctoral Fellowship in Pharmaceutical Science |
PHILIP
E. EMPEY |
University
of Kentucky College of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA:
|
3.97 |
Graduation
Date: |
Dec-05 |
Focus
of Research: |
Xenobiotic
transport proteins have been implicated in phenomena involving unexpected
exposure or response to medications. A goal of the research is to
identify potential candidate drug transport proteins that may be involved
in drug accumulation in milk and to investigate the molecular mechanisms
of transporter gene regulation in mammary epithelium. |
Title
of Dissertation: |
“Xenobiotic
Transporter Gene Expression in Lactating Mammary Epitheilum.” |
Degrees
Received: |
Pharm.D.,
University Rhode Island, May 1998 |
Honors
Received: |
2002,
Pre-Doctoral Fellow, NIH Reproductive Sciences Training Grant; 2001,
BCPS Certification; 2001-00, Extra Mile Award, UUK Pharmacy Residency;
1998, ACCP-Merck Undergraduate Research Scholar; 1998-92 Dean’s List;
1993, Rho Chi High Scholastic Achievement Award |
AFPE
Award: |
Proctor
& Gamble Fund-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
TIA B.
ESTEY |
University
of Colorado Health Sciences Center School of Pharmacy |
Major: |
Pharmaceutical
Sciences |
GPA:
|
3.93/4.00 |
Graduation
Date: |
May-05 |
Focus
of Research: |
To
develop a stable, controlled-release protein delivery system. Currently,
the administration of protein therapeutics is limited to injection,
which requires painful daily injections for patients needing chronic
treatment. Encapsulating proteins within a biodegradable polymer,
such as poly(lactide-co-glycolide) (PLGA), can provide a continual
release of protein for weeks to months. Controlled-release of therapeutic
proteins is a desirable alternative to the current standard but has
been limited due to the instability of proteins within such systems. |
Title
of Dissertation: |
“Increasing
Protein Stability within PLGA Delivery Systems.” |
Degrees
Received: |
B.S.,
Biological Sciences, University of Denver, June 1999 |
Honors
Received: |
2003,
AFPE Pre-Doctoral Fellow; 2003, Nominated for UCHSC Ethics Committee,
Student Representative; 2002, NIH Leadership Training Fellowship Grant
Renewal; 2001, NIH Leadership Training in Pharmaceutical Biotechnology
Fellow; 2001, 1st Place Student Podium Presentation, UCHSC Annual
Research; 2001, 1st Place Student Podium Presentation, MWSOT Annual
Meeting; 1998, PINS Research Grant, University of Denver; 1998, Pustmueller
Undergraduate Research Fellow; 1995, Honors Program and Scholarship,
University of Denver |
AFPE
Award: |
Wyeth-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
JOEL F.
FARLEY |
University
of Minnesota College of Pharmacy |
Major
|
Social
& Administrative Sciences |
GPA:
|
3.94/4.00 |
Graduation
Date: |
May-05 |
Focus
of Research: |
Prescription
managed care practices and the impact of these practices on the utilization
of other health care services. |
Title
of Dissertation: |
“An
Examination of Unintended Consequences and Policy Effectiveness in
prescription Prior Authorization Programs.” |
Degrees
Received: |
B.S.,
Pharmacy, University of Wisconsin, May 1997 |
Honors
Received: |
2003,
AFPE Pre-Doctoral Fellow; 1997-1995, Pharmacy School Honor Roll |
AFPE
Award: |
NACDS-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
DAVID J.
FEOLA |
University
of Kentucky College of Pharmacy |
Major: |
Pharmaceutical
Sciences |
GPA: |
3.37/4.00 |
Graduation
Date: |
Dec-05 |
Focus
of Research: |
To
examine synergistic drug toxicity, which combines the disciplines
of immunology, toxicology, and infectious diseases pharmacology and
utilize a translational component to investigate its clinical significance. |
Title
of Dissertation: |
“Combination
of Sulfamethoxazole/Trimethoprim (SMX/TMP) and Zidovudine (ZDV): Investigation
of Synergistic Bone Marrow Toxicity in Mice.” |
Degrees
Received: |
Pharm.D.,
University of Kentucky, May 1997, B.S., Pharmacy, University of Kentucky,
December 1996 |
Honors
Received: |
2003-02,
AFPE Pre-Doctoral Fellowship; 2001, BCPS Certification; 2001, UKMC
Outstanding Pharmacy Resident Award; 2000, UKMC Residency Program
Impact Award; 1997-1995, UKCOP Dean EP Sloan Leadership Award; 1997,
UKCOP Outstanding Graduating Man Award; 1995, UKCOP Kappa Psi Graduate
Chapter Award |
AFPE
Award: |
AstraZeneca-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
JULIE GAASCH |
Texas
Tech University Health Science Center School of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA:
|
3.7/4.0 |
Graduation
Date: |
Aug-06 |
Focus
of Research: |
Osteoclast
cells play a critical role in the development of osteoporosis. The
research goal is to identify and characterize osteoclast-specific
transcripts to be used to inhibit bone resorption. |
Title
of Dissertation: |
“New
Molecular Targets to Inhibit Osteoclast Migration and Bone Resorption.” |
Degrees
Received: |
B.S.,
Chemistry/Biology, West Texas A&M University, M2001 |
Honors
Received: |
2001-99,
President of WAMU Pre-Medicine Club; 2000, Beta Beta Beta Honor Society
Academic Scholarship; 1999, Induction into Mortar Baord Honor Society;
1996, Amarillo Area Foundation Academic Scholarship |
AFPE
Award: |
NACDS-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
GIULIA
GHIBELLINI |
University
of North Carolina at Chapel Hill School of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA: |
N/A |
Graduation
Date: |
Mar-06 |
Focus
of Research: |
Establishing
in-vitro and in-vivo correlations of biliary clearance of drugs in
humans. Values of biliary clearance obtained in healthy volunteers
will be compared to data generated in the sandwich-clutured human
hepatocytes and other in-vitro models. |
Title
of Dissertation: |
“Development
of In-Vitro and In-Vivo Models To Predict Hepatobiliary Clearance
In Humans.” |
Degrees
Received: |
M.S.,
Pharmaceutical Sciences, Universita Degli Studi Di Bologna, Italy,
February 1998 |
Honors
Received: |
1998,
Leonardo Da Vinci Grant |
AFPE
Award: |
Serono
Inc.-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
JOHN R.
GOODELL |
University
of Minnesota College of Pharmacy |
Major: |
Medicinal/Pharmaceutical
Chemistry |
GPA: |
3.82/4.00 |
Graduation
Date: |
Aug-05 |
Focus
of Research: |
To
synthesize and evaluate a series of non-nucleoside heterocyclic compounds
for their anti-viral activity against H5V-1 HSV-2 and HIV and to elucidate
the mechanism of action. The knowledge gained is intended to lead
to a better understanding of the structure activity relationships
for this novel series of compounds. |
Title
of Dissertation: |
“Non-nucleoside
Antiviral Agents with a Novel Mechanism.” |
Degrees
Received: |
B.S.,
ACS-Chemistry-Biochemistry, University of Wisconsin-River Falls, June
2000 |
Honors
Received: |
2003-02,
AFPE Pre-Doctoral Fellowship; 2000-1996, Dean’s List |
AFPE
Award: |
GlaxoSmithKline-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
XINYI GU |
University
of Michigan School of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA:
|
8.3/9.0 |
Graduation
Date: |
Sep-07 |
Focus
of Research: |
To
enhance the targeting specificity of chemotherapeutic agents using
a two component system. The first component is an antibody enzyme
complex while the second component is a stealth nanoparticle encapsulating
chemotherapeutic drugs. |
Title
of Dissertation: |
“Antibody-Directed
Enzyme-Cleavable Stealth Nanoparticle Therapeutics System.” |
Degrees
Received: |
B.S.,
Biochemistry, University of Illinois-Urbana Champaign |
Honors
Received: |
2003-02,
Fred Lyons Fellowship; 2002-98, UIUC James Scholar; 2002, UIUC Bronze
Tablet Recipient |
AFPE
Award: |
Johnson
& Johnson-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
JASON HELD |
University
of California at San Francisco School of Pharmacy |
Major
|
Pharmaceutical
Sciences |
GPA:
|
3.84/4.0 |
Graduation
Date: |
Nov-05 |
Focus
of Research: |
DAF-12
as a nuclear receptor that is a major determinant of the complex phenotypes
of dauer formation, adult stress resistance, and lifespan in the nematode
C. elegans based on genetic studies. DAF-12 integrates a series of
environmental conditions and signaling pathways to alter the worm
life history. Mass spectrometric methods will be used to investigate
the dauer-specific alterations in DAF-12 to gain insight into how
nuclear receptors are able to modulate such a complex phenotype. The
specific research aim is to determine the nature of dauer-specific
DAF-12 PTMs, to identify DAF-12 interacting proteins including corepressors,
coactivators, and heterodimerization partners, and to identify the
endogenous DAF-12 ligand. |
Title
of Dissertation: |
“DAF-12’s
role in the Molecular Mechanism of C. Elegans Dauer Regulations.” |
Degrees
Received: |
B.S.
Biology, Duke University, May 2001 |
Honors
Received: |
2001,
Achievement Rewards for College Scientists Foundation Scholar; 2000,
Howard Hughes Undergraduate Neuroscience Fellow; 1999, Undergraduate
Research Grant Recipient from Duke University; 1997, American Chemical
Society Award for Excellence in Chemistry |
AFPE
Award: |
AAPS-AFPE
Fellowship in Pharmaceutical Science |
JEFFREY
N. HEMENWAY |
University
of Kansas School of Pharmacy |
Major: |
Medicinal/Pharmaceutical
Chemistry |
GPA: |
3.89/4.00 |
Graduation
Date: |
Jun-05 |
Focus
of Research: |
To
develop new water-soluble pro-drugs of carbamazepine and oxcarbamazepine
that are suitable for parenteral and oral delivery and to determine
the feasibility, using this acyl-urea pro-drug approach, of enhance
the delivery characteristics of poorly water-soluble drugs. |
Title
of Dissertation: |
“Preparation,
Physicochemical Properties, and Animal Studies of New Acyl-Urea Pro-Drugs
of Carbamazepine and Oxcarbazepines.” |
Degrees
Received: |
M.S.,
Pharmaceutics, University of Kansas, January 2002, B.S., Chemistry,
University of Missouri-Kansas City, December 1997, A.A., Arts, Longview
Community College, June 1994 |
Honors
Received: |
2003-2000,
Perdue Pharma Tuition Fellowship; 2003-02, AFPE Pre-Doctoral Fellowship;
1999, Frank B. Dains Award; 1999, H.P. Cady Award; 1997-1995, Departmental
Honors; 1997-1995, Dean’s List |
AFPE
Award: |
Josiah
Kirby Lilly, Sr. Memorial Pre-Doctoral Fellowship in the Pharmaceutical
Sciences |
ELIZABETH
J. HOHNADEL |
University
of Georgia School of Pharmacy |
Major
|
Pharmacology/Toxicology |
GPA:
|
3.64/4.0 |
Expected
Graduation: |
May-06 |
Focus
of Research: |
Neuroleptic
treatment of psychiatric disorders (e.g. autism, schizophrenia) in
children and adolescents may have adverse effects on cognitive and
physiological development. The research aim is to determine the safest
and most effective neuroleptic for young populations. |
Title
of Dissertation: |
“Evaluation
of Atypical Versus Typical Antipsychotic Strategies in a Neurodevelopmental
Rat Model of Schizophrenia.” |
Degrees
Received: |
M.S.,
Biology, Georgia College & State University, August 2002
M. Ed., Outdoor Education, Georgia College & State University, May
1998
B.S., Biology, Presbyteriat College, May 1992 |
Honors
Received: |
N/A |
AFPE
Award: |
AFPE
21st Century Club Pre-Doctoral Fellowship in Pharmaceutical Science
|
TERRENCE
R. JACKSON |
University
of Illinois at Chicago College of Pharmacy |
Major:
|
Social
& Administrative Sciences |
GPA:
|
4.96/5.00 |
Expected
Graduation: |
May-05 |
Focus
of Research: |
To
develop a benchmark assessment for pharmaceutical care delivery in
the self-care arena. The benchmark will be supported via an evaluative
instrument that assesses pharmacy students’ abilities when they interact
with simulated patients regarding prescription and nonprescription
medication therapy. An assessment instrument is being developed consisting
of a series of six standardized patients in an objective structured
clinical evaluation (OSCE) format. |
Title
of Dissertation: |
“Objective
Structured Clinical Examinations (OSCEs) Using Standardized Patients
to Assess Student Performance: A Benchmark for the Delivery of Nonprescription
Medicines Care.” |
Degrees
Received: |
M.S.,
Pharmaceutical Sciences, University of Arizona, August 2001
Pharm.D., University of Arizona, May 1998
B.S., Biology, University of Arizona, May 1998 |
Honors
Received: |
2003,
AFPE Pre-Doctoral Fellow; 2003, Jessie Stewart Award and Paul Lang
Award in Pharmacy Administration; 2002, W.E. Van Doren Scholar; 1999,
American Lung Association of Arizona Volunteer Award; 1999, Who’s
Who Among Students in American Universities and Colleges; 1998, American
Pharmaceutical Association, Academy of Students of Pharmacy, Senior
Recognition Certificate; 1998, Phi Lambda Sigma-GlaxoSmithKline-AFPE-First
Year Graduate School Scholarship; 1997, G.D. Searle Fellowship in
Pharmacy Award; 1997, Arizona Pharmacy Association Pharmacy Appreciation
Award; 1997, American Association of Colleges of Pharmacy Council
of Faculties, Innovations in Teaching Award; 1997, American Pharmaceutical
Association Student Leadership Award |
AFPE
Award: |
Abbott
Laboratories Fund-AFPE Pre-Doctoral Fellowship in Pharmaceutical Science |
TARA L.
JENKINS |
University
of Oklahoma Health Sciences Center College of Pharmacy |
Major
|
Social
& Administrative Sciences |
GPA:
|
3.73
/ 4.00 |
Expected
Graduation: |
May-05 |
Focus
of Research: |
The
decision-making process that patients utilize in deciding to search
for medical information on the Internet in addition to analyzing the
decision they make after concluding their search. |
Title
of Dissertation: |
“Impact
of the Internet on Patients’ Health Decision Making.” |
Degrees
Received: |
B.S.,
Pharmacy, University of Oklahoma, May 2000 |
Honors
Received: |
2004,
E. Blanche Sommers Award; 2003, AFPE Pre-Doctoral Fellow; 2003, Loyd
E. and Maurine Harris Award; 2002, E. Blanche Sommers Award; 2000,
Provost Pre-doctoral Fellowship; 2000, Merck Outstanding Research
Award; 2000, Oklahoma University ASP Pt. Counseling Comp. Winner;
2000, PLS Outstanding Member (OU Chapter); 2000, ASP (OU Chapter)
Outstanding Member; 2000, Phi Delta Chi (Rho Chapter) Outstanding
Graduate Member; 1999, Oklahoma University ASP Pt. Counseling Comp.
Runner-up |
AFPE
Award: |
APhA-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
CORY S.
KENDING |
University
of Minnesota College of Pharmacy |
Major
|
Medicinal/Pharmaceutical
Chemistry |
GPA:
|
3.76/4.0 |
Expected
Graduation: |
Sep-07 |
Focus
of Research: |
To
develop a series of analogues of substituted 5.5.5 spirobicyclic peptide
mimics, which have shown promising biological activity to the PLG
receptor. The substitutions in this series are designed to mimic the
critical sidechain interactions between PLG and its receptor. |
Title
of Dissertation: |
“Synthesis
of Position 2, b-substituted 5.5.5 Spiro Bicyclic Type II b-turn.” |
Degrees
Received: |
B.A.,
Biochemistry, Knox College, June 1998 |
Honors
Received: |
1998,
Knox College Biochemistry Award; 1998, Mortar Board; 1998-94, Hormana
R. Mueller Scholar; 1998-94, Dean’s List |
AFPE
Award: |
USP-AFPE
Pre-Doctoral Fellowship in Medicinal/Pharmaceutical Chemistry |
BRIAN
R. KEPPLER |
University
of North Carolina School of Pharmacy |
Major: |
Medicinal/Pharmaceutical
Chemistry |
GPA:
|
N/A |
Expected
Graduation: |
Dec-05 |
Focus
of Research: |
Investigating
small molecule interactions with the RNA subunit of telomerase. The
research hypothesis is that appropriately designed human telomerase
RNA-binding ligands will affect telomerase assemblage and perturb
enzymatic activity. The goal of the research project is to provide
a novel approach to control cellular immortality and provide a new
anticancer drug modality. |
Title
of Dissertation: |
"Identifying
Inhibitors of Telomerase Assemblage.” |
Degrees
Received: |
B.S.,
Chemistry, Emory University, May 2000 |
Honors
Received: |
2004,
Impact Award; 2004, Alpha Epsilon Lambda Honor Society; 1997, Phi
Eta Sigma Honor Society |
AFPE
Award: |
USP-AFPE
Pre-Doctoral Fellowship in Medicinal/Pharmaceutical Chemistry |
YVONNE
Y. LAU |
University
of California at San Francisco School of Pharmacy |
Major:
|
Pharmacokinetics/Metabolism |
GPA:
|
3.88/4.00 |
Expected
Graduation: |
Jun-06 |
Focus
of Research: |
Focus
is on hepatic transporters and how they may control the access of
drug molecules to metabolizing enzymes: changes in transporter function
can change hepatic metabolism without apparent affecting enzyme activity. |
Title
of Dissertation: |
“Examining
the Regulation of Hepatic Drug Disposition and Metabolism by Organic
Anion Transporting Polypeptide (OATP-C) and P-glycoprotein (P-gp).” |
Degrees
Received: |
B.S.,
Biomedical Engineering, Johns Hopkins University, May 2001 |
Honors
Received: |
2003,
AFPE Pre-Doctoral Fellow; 2001, Tau Beta Pi, National Engineering
Honor Society; 2000, Provost’s Undergraduate Research Awards; 2000,-97,
Dean’s List; 1999, Alpha Eta Mu Beta, National Biomedical Engineering
Honor Society |
AFPE
Award: |
Novo
Nordisk-AFPE Pre-Doctoral Fellowship in the Pharmacokinetics/Metabolism |
JENNIFER
S. LINKS |
University
of Southern California School of Pharmacy |
Major:
|
Pharmaceutical
Sciences |
GPA:
|
4.00/4.00 |
Expected
Graduation: |
May-05 |
Focus
of Research: |
The
human intestinal dipeptide transporter hPepT1 has a wide substrate
specificity that has lead many pharmaceutical companies to use combinatorial
chemistry to develop hPepT1 targeted drugs. The research focus is
to improve this process by mapping out the substrate interactions
of PepT1. |
Title
of Dissertation: |
“Mapping
the Substrate Binding Site of hPepT1.” |
Degrees
Received: |
B.S.,
Molecular, Cell, and Developmental Biology, University of California
at Los Angeles, June 2001 |
Honors
Received: |
2004,
Outstanding Senior Recognition Award; 2004, Outstanding Executive
Board Member; 2003, AFPE Pre-Doctoral Fellow; 2002, 3rd Place Poster
at “Moving Targets”; 2000, Outstanding Theoretical Lab Practice; 2000,
Outstanding Technical Lab Practice; 1997, Latin Gold Medallion of
Excellence; 1997, Senior Latin Award; 1997, Senior Music Award |
AFPE
Award: |
ACPE-AFPE
Pre-Doctoral Fellowship in the Pharmaceutical Sciences |
JOHN R.
LITAKER |
University
of Texas at Austin College of Pharmacy |
Major:
|
Social
& Administrative Sciences |
GPA:
|
3.85/4.00 |
Expected
Graduation: |
Dec-04 |
Focus
of Research: |
This
research focuses on efficiency aspects related to the provision of
care for workers’ compensation patients in Texas. Specifically, this
research focuses on identifying patient, physician, and environmental
characteristics that lead to high cost and high medical service utilization
by workers’ compensation recipients. In turn, by identifying key drivers
of high cost and high medical service utilization, policy decisions
regarding the provision or appropriate and cost-effective care can
be made. |
Title
of Dissertation: |
“The
Impact of Lost Time and Disability Management Programs on Healthcare
Service Utilization and Expenditures Among Texas Workers’ Compensation
Commissions Claimants.” |
Degrees
Received: |
M.Sc.,
Medical Science, University of Hong Kong, December 1998
M.Sc., Public Health, London School of Hygiene & Tropical Medicine,
December 1997
B.A., Geography, University of North Carolina-Chapel Hill, May 1996 |
Honors
Received: |
2003,
AFPE Pre-Doctoral Fellow; 2002, University of Texas Excellence in
Teaching Assistantship Award; 2001, University of Texas Recruiting
Fellowship Award; 1998, Rotary Ambassadorial Scholarship to study
at the University of Hong Kong; 1995, American Cartographical Scholarship
Award |
AFPE
Award: |
NABP-AFPE
Pre-Doctoral Fellowship in Pharmaceutical Science |
THONG C.
MA |
Ohio
State University College of Pharmacy |
Major
|
Pharmacology/Toxicology |
GPA:
|
3.83/4.0 |
Expected
Graduation: |
Jun-06 |
Focus
of Research: |
Focus
of research is on protein tyrosine nitration as a marker for oxidative
damage mediated by peroxynitrite formation and is elevated in the
brain tissue of Parkinson’s disease (PD) patients. The biological
consequences of tyrosine nitration are largely unexplored. |
Title
of Dissertation: |
“
The Molecular Mechanisms of Free 3-nitrotyrosine Neurotoxicity.” |
Degrees
Received: |
B.S.,
Pharmacy, Ohio State University, December 2001, Summa Cum Laude |
Honors
Received: |
2002,
Faegles Memorial Award |
AFPE
Award: |
Sankyo
Pharma-AFPE Pre-Doctoral Fellowship in Pharmacology/Toxicology |
BETH MARTIN |
University
of Wisconsin-Madison School of Pharmacy |
Major
|
Social
& Administrative Sciences |
GPA:
|
4.0/4.0 |
Expected
Graduation: |
May-05 |
Focus
of Research: |
To
assess whether behavior performance can be measured in a simulated
practice situation. This measurement is critical to validate the impact
that a well-designed professional education program can ultimately
have on professional behavior through the transfer of skills to the
work place. A comprehensive tobacco cessation training program is
the basis for this research. |
Title
of Dissertation: |
“Using
Observational Research to Study the Impact of a Continuing Professional
Education Program on Pharmacists’ Behavioral Performance.” |
Degrees
Received: |
M.S.,
Social & Administrative Sciences, University of Wisconsin-Madison,
May 2003
B.S., Pharmacy, University of Wisconsin-Madison, May 1990 |
Honors
Received: |
2004,
APhA-ARPS ESAS Postgraduate Officer; 2003, APhA-APRS ESAS Postgraduate
Best Paper Finalist; 2001, AAACP Innovative Teaching Award; 1999,
Teaching Excellence Award; 1995, WPhA Yong Pharmacist of the Year
Award |